• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Weighing the Benefits and Risks of Proliferating Observational Treatment Assessments: Observational Cacophony, Randomized Harmony.

作者信息

Califf Robert M, Hernandez Adrian F, Landray Martin

机构信息

Verily Life Sciences (Alphabet), South San Francisco, California.

Duke Clinical Research Institute, Durham, North Carolina.

出版信息

JAMA. 2020 Aug 18;324(7):625-626. doi: 10.1001/jama.2020.13319.

DOI:10.1001/jama.2020.13319
PMID:32735313
Abstract
摘要

相似文献

1
Weighing the Benefits and Risks of Proliferating Observational Treatment Assessments: Observational Cacophony, Randomized Harmony.权衡不断增加的观察性治疗评估的益处与风险：观察性杂音与随机和谐
JAMA. 2020 Aug 18;324(7):625-626. doi: 10.1001/jama.2020.13319.
2
Registry-based randomized controlled trials merged the strength of randomized controlled trails and observational studies and give rise to more pragmatic trials.基于注册的随机对照试验结合了随机对照试验和观察性研究的优势，产生了更具实用性的试验。
J Clin Epidemiol. 2018 Jan;93:120-127. doi: 10.1016/j.jclinepi.2017.09.017. Epub 2017 Sep 22.
3
COVID-19, equipoise and observational studies: a reminder of forgotten issues.2019冠状病毒病、 equipoise（平衡原则）与观察性研究：对被遗忘问题的提醒
Infection. 2021 Apr;49(2):371-373. doi: 10.1007/s15010-020-01466-9. Epub 2020 Jun 25.
4
COVID-19 studies registration worldwide for prospective studies with a specific focus on the fast-tracking of French ethic procedures.全球范围内针对COVID-19的前瞻性研究注册，特别关注法国伦理程序的快速推进。
Anaesth Crit Care Pain Med. 2020 Aug;39(4):481-482. doi: 10.1016/j.accpm.2020.06.010. Epub 2020 Jun 30.
5
Randomized  Controlled Trials Versus Real-World Data in the COVID-19 Era: A False Narrative.新冠疫情时代的随机对照试验与真实世界数据：一种错误的说法。
Cancer Invest. 2020 Nov;38(10):537-542. doi: 10.1080/07357907.2020.1841922. Epub 2020 Nov 5.
6
Opportunities and Challenges of Observational Studies and Randomized Controlled Trials for Evaluating the Therapeutic Efficacy of COVID-19 Convalescent Plasma.评估 COVID-19 恢复期血浆治疗疗效的观察性研究和随机对照试验的机遇与挑战。
Cancer Invest. 2021 Jul-Aug;39(6-7):449-456. doi: 10.1080/07357907.2021.1942127. Epub 2021 Jul 5.
7
A survey of 434 clinical trials about coronavirus disease 2019 in China.一项关于中国2019年冠状病毒病的434项临床试验的调查。
J Med Virol. 2020 Oct;92(10):1715-1717. doi: 10.1002/jmv.25779. Epub 2020 Mar 27.
8
[Not Available].[无可用内容]
Recenti Prog Med. 2019 Nov;110(11):524-525. doi: 10.1701/3265.32327.
9
Stent Omission after Ureteroscopy and Lithotripsy (SOUL) in the Michigan Urological Surgery Improvement Collaborative (MUSIC): study protocol for a pragmatic prospective combined randomized and observational clinical trial.密歇根泌尿外科手术改进协作组（MUSIC）的输尿管镜检查和碎石术后支架遗漏（SOUL）研究：一项实用的前瞻性随机与观察性联合临床试验的研究方案
Trials. 2024 Dec 4;25(1):811. doi: 10.1186/s13063-024-08587-8.
10
Real-world studies no substitute for RCTs in establishing efficacy.在确定疗效方面，真实世界研究无法替代随机对照试验。
Lancet. 2019 Jan 19;393(10168):210-211. doi: 10.1016/S0140-6736(18)32840-X.

引用本文的文献

1
Use of real-world evidence in the Medicare Drug Price Negotiation Program: A checklist for the Centers for Medicare and Medicaid Services and manufacturers.在医疗保险药品价格谈判计划中使用真实世界证据：给医疗保险和医疗补助服务中心及制造商的一份清单。
Health Aff Sch. 2025 Mar 21;3(3):qxaf030. doi: 10.1093/haschl/qxaf030. eCollection 2025 Mar.
2
Barriers to optimizing inflammatory bowel disease care in the United States.美国优化炎症性肠病护理的障碍。
Therap Adv Gastroenterol. 2023 May 5;16:17562848231169652. doi: 10.1177/17562848231169652. eCollection 2023.
3
Responsible conduct of research: Preparedness for times of crisis.
负责任的研究行为：应对危机时刻的准备
J Clin Transl Sci. 2023 Mar 8;7(1):e83. doi: 10.1017/cts.2023.13. eCollection 2023.
4
Data quality considerations for evaluating COVID-19 treatments using real world data: learnings from the National COVID Cohort Collaborative (N3C).利用真实世界数据评估 COVID-19 治疗方法的数据质量考量因素：来自国家 COVID 队列协作组织（N3C）的经验教训。
BMC Med Res Methodol. 2023 Feb 17;23(1):46. doi: 10.1186/s12874-023-01839-2.
5
Teaching a Deeper Understanding of the Medical Literature.培养对医学文献更深入的理解。
J Gen Intern Med. 2023 Mar;38(4):1059-1060. doi: 10.1007/s11606-022-07851-4. Epub 2022 Oct 31.
6
Alcohol, Drinking Pattern, and Chronic Disease.酒精、饮酒模式与慢性疾病。
Nutrients. 2022 May 7;14(9):1954. doi: 10.3390/nu14091954.
7
Biomedical Research COVID-19 Impact Assessment: Lessons Learned and Compelling Needs.生物医学研究中的 COVID-19 影响评估：经验教训与迫切需求
NAM Perspect. 2021 Jul 26;2021. doi: 10.31478/202107e. eCollection 2021.
8
Making trials part of good clinical care: lessons from the RECOVERY trial.将试验纳入优质临床护理：RECOVERY试验的经验教训。
Future Healthc J. 2021 Jul;8(2):e243-e250. doi: 10.7861/fhj.2021-0083.
9
Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide Evidence.COVID-19的恢复期血浆疗法：全球证据的图形汇总
Front Med (Lausanne). 2021 Jun 7;8:684151. doi: 10.3389/fmed.2021.684151. eCollection 2021.
10
When Can We Rely on Real-World Evidence to Evaluate New Medical Treatments?何时我们可以依靠真实世界证据来评估新的医疗疗法？
Clin Pharmacol Ther. 2022 Jan;111(1):30-34. doi: 10.1002/cpt.2253. Epub 2021 May 19.